Neuroimmunology and disease models

Tuesday, October 26, 2021: 5:00 PM-7:00 PM
Exhibit Hall (Rosen Shingle Creek)
Clinical and Diagnostic Spectrum of Optic Neuritis: A Single-Center Retrospective Study of Disorders Associated with Multiple Sclerosis, Aquaporin-4 Antibody, and Myelin Oligodendrocyte Glycoprotein Antibody
Dana Siegel, MD, Wayne State University, School of Medicine; Meredith Van Harn, MPH, Henry ford health system; Poonam Bansal, MD, Henry Ford Health System; Mirela Cerghet, MD, PhD, Henry Ford Hospital; Anza B Memon, MD, Henry Ford Health System, Wayne State University, School of Medicine

RGC-32 Contributes to Reactive Astrocytosis in Experimental Autoimmune Encephalomyelitis By Maintaining a Mature Phenotype
Austin J Beltrand, Medical Student, University of Maryland SOM; Horea Rus, MD, PhD, Veterans Administration Multiple Sclerosis Center of Excellence; Alexandru Tatomir, MD, University of Maryland SOM

Comparing Infection-Related Outcomes By Sex in Patients with Multiple Sclerosis and Matched Controls Using Administrative Claims Data
Riley Bove, MD, UCSF Weill Institute for Neurosciences, University of California; Terra Slaton, MS, CK Consulting Associates, LLC; Chris M. Kozma, PhD, CK Consulting Associates, LLC; Amy L. Phillips, PharmD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA; Danielle E. Harlow, PhD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA; Carroline Lobo, PhD, EMD Serono, Inc., Rockland, MA, USA, an affiliate of Merck KGaA

Effect of Ocrelizumab on Antibody Responses to EBV
Kaleigh E Olmsted, B.S., McGovern Medical School; John W Lindsey, MD, McGovern Medical School

Mucosal Associated Invariant T (MAIT) Cells Show Defective Activation in People with Multiple Sclerosis
Laura Ghezzi, MD, Washington University in St. Louis, University of Milan; Claudia Cantoni, PhD, Washington University in St. Louis; Daniela Galimberti, PhD, University of Milan; Elio Scarpini, MD, University of Milan; Anne Cross, MD, Washington University in St. Louis; Laura Piccio, M.D., Ph.D, Washington University in St. Louis, University of Sydney

Phenotype and Functional Characterization of B-Cells, T-Cells and Monocytes Following Alemtuzumab Treatment in Patients with Multiple Sclerosis.
Nicole Kashani, M.D., University of Southern California; Borna Vajdi, M.D., University of Southern California; Lauren M Anderson, B.S., University of Southern California; Gregory Baltayan, B.S., University of Southern California; Eve E Kelland, Ph.D., University of Southern California; Wendy Gilmore, Ph.D., University of Southern California; Brett T Lund, Ph.D., University of Southern California


See more of: Posters